Avricore Health Inc. AVCRF

Company Overview

Avricore Health Inc. is a Canadian healthcare technology and diagnostics company focused on point-of-care testing, data connectivity, and pharmacy-based health screening services. The company operates primarily in the community healthcare, diagnostics, and digital health sectors, with an emphasis on improving access to real-time clinical testing through retail pharmacy networks. Its core platform, HealthTab, integrates diagnostic screening technologies with cloud-based data management tools to support pharmacists, healthcare providers, and patients in chronic disease monitoring and preventive care initiatives.

The company’s primary revenue drivers include diagnostic testing services, technology platform licensing, and partnerships with pharmacy operators and healthcare organizations. Avricore Health has positioned itself within the growing decentralized healthcare and preventive diagnostics market by enabling rapid testing workflows in retail pharmacy environments. Historically, the company evolved from broader healthcare and wellness activities into a more focused diagnostics and health technology business, particularly after expanding the HealthTab platform and forming commercial relationships with major pharmacy operators in Canada.

Business Operations

Avricore Health conducts operations primarily through its diagnostic and health technology activities centered around the HealthTab platform. The platform combines point-of-care testing devices, cloud-based reporting infrastructure, and pharmacist workflow integration to deliver rapid screening for biomarkers related to cardiovascular health, diabetes management, and chronic disease risk assessment. Revenue generation is tied to testing volumes, technology deployment, recurring service arrangements, and strategic healthcare partnerships.

The company’s operations are concentrated mainly in Canada, though its technology model has potential applicability in broader international pharmacy and decentralized care markets. Avricore Health has collaborated with pharmacy groups and diagnostic technology providers to support the rollout of in-pharmacy testing services. Public disclosures identify partnerships involving pharmacy chains and healthcare distribution networks, while the company also utilizes third-party diagnostic equipment integrated into its software ecosystem. Data inconclusive based on available public sources regarding the scale of international commercial deployment.

Strategic Position & Investments

Avricore Health’s strategic direction centers on expanding pharmacy-based diagnostic screening and advancing connected healthcare infrastructure that links patients, pharmacists, and healthcare practitioners through real-time testing data. The company has emphasized chronic disease prevention, early intervention, and decentralized healthcare delivery as key long-term market opportunities. Growth initiatives have included expanding the footprint of HealthTab locations, increasing test menu capabilities, and strengthening relationships with pharmacy operators and healthcare stakeholders.

The company has also pursued technology integration and commercialization initiatives intended to support recurring healthcare engagement within retail pharmacy settings. Public filings and corporate disclosures reference investments in diagnostic interoperability, data management systems, and scalable pharmacy testing infrastructure. Strategic positioning has been influenced by broader healthcare trends favoring accessible community-based care and digital health monitoring. Data inconclusive based on available public sources regarding material acquisitions or large-scale international investment holdings.

Geographic Footprint

Avricore Health is headquartered in British Columbia, Canada, and its principal operational footprint is within the Canadian healthcare and pharmacy market. The company’s activities have been concentrated in partnerships with Canadian pharmacy operators and healthcare service providers, particularly in urban and community retail pharmacy environments. Its market presence is strongest in Canada, where regulatory frameworks and pharmacy healthcare expansion initiatives support point-of-care testing adoption.

While the company’s technology platform has potential relevance for broader international healthcare applications, publicly available information indicates that commercial operations remain primarily Canadian-focused. Avricore Health’s operational influence is tied more to healthcare technology enablement and pharmacy diagnostics than to large multinational infrastructure ownership. Data inconclusive based on available public sources regarding material direct operations outside Canada.

Leadership & Governance

Avricore Health’s leadership team has focused on expanding decentralized diagnostics and integrating technology-enabled healthcare delivery into pharmacy settings. Corporate strategy has emphasized preventive care, accessibility, and scalable diagnostic services supported by digital infrastructure. The company operates under a publicly traded governance structure and provides disclosures through Canadian securities filings and investor communications.

Key executives and leadership figures include:

• Hector Bremner – Chief Executive Officer
• Malcolm Burrows – Chief Financial Officer
• Paul Chirico – Director
• Shital Marsan – Corporate Secretary

Public communications from leadership have consistently emphasized healthcare accessibility, pharmacy-based clinical services, and technology-driven preventive care models as central strategic priorities. Data inconclusive based on available public sources regarding additional executive leadership roles or expanded subsidiary leadership structures.